Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.30 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5615295 | 0.97 | TSHR (0.42) | TSHRTHRBLMNAMEN1HTT | |
| SCHEMBL5615425 | 0.97 | TSHR (0.42) | TSHRTHRBLMNAMEN1HTT | |
| SCHEMBL8651054 | 0.97 | TSHR (0.42) | TSHRTHRBLMNAMEN1HTT | |
| SCHEMBL5615509 | 0.97 | TSHR (0.42) | TSHRTHRBLMNAMEN1HTT | |
| SCHEMBL5615189 | 0.97 | TSHR (0.42) | TSHRTHRBLMNAMEN1HTT | |
| SCHEMBL5615452 | 0.97 | TSHR (0.42) | TSHRTHRBLMNAMEN1HTT | |
| SCHEMBL5615496 | 0.97 | TSHR (0.42) | TSHRTHRBLMNAMEN1HTT | |
| SCHEMBL9785047 | 0.87 | TSHR (0.38) | TSHRTHRBLMNAMEN1HTT | |
| SCHEMBL17395690 | 0.87 | TSHR (0.38) | TSHRTHRBLMNAMEN1HTT | |
| SCHEMBL17395687 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1620068-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL (FR) | 2006-02-01 | — | — | EP | claimed |
| WO-2004087077-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL (FR) | 2004-10-14 | — | — | WO | claimed |
| EP-3507104-B1 | PRODUCTION OF CIS-1,4-POLYDIENES WITH MULTIPLE SILANE FUNCTIONAL GROUPS PREPARED BYIN-SITU | BRIDGESTONE CORP (JP) | 2024-03-27 | — | — | EP | disclosed |
| US-20230089837-A1 | POLYMERIZATION PROCESSES FOR THE PRODUCTION OF CIS-1,4-POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2023-03-23 | — | — | US | disclosed |
| US-20230038639-A1 | POLYMERIZATION PROCESSES FOR THE PRODUCTION OF CIS-1,4-POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2023-02-09 | — | — | US | disclosed |
| WO-2021133819-A1 | POLYMERIZATION PROCESSES FOR THE PRODUCTION OF CIS-1,4-POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2021-07-01 | — | — | WO | disclosed |
| WO-2021133818-A1 | POLYMERIZATION PROCESSES FOR THE PRODUCTION OF CIS-1,4-POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2021-07-01 | — | — | WO | disclosed |
| US-10975178-B2 | Production of cis-1,4-polydienes with multiple silane functional groups prepared by in-situ hydrosilylation of polymer cement | BRIDGESTONE CORPORATION (JP) | 2021-04-13 | — | — | US | disclosed |
| US-10899718-B2 | Polymers functionalized with N-protected hydantoin compounds | BRIDGESTONE CORPORATION (JP) | 2021-01-26 | — | — | US | disclosed |
| EP-2516475-B1 | POLYMERS FUNCTIONALIZED WITH POLYOXIME COMPOUNDS AND METHODS FOR THEIR MANUFACTURE | BRIDGESTONE CORP (JP) | 2020-10-07 | — | — | EP | disclosed |
| US-20190211120-A1 | Production Of Cis-1,4-Polydienes With Multiple Silane Functional Groups Prepared By In-Situ Hydrosilylation Of Polymer Cement | BRIDGESTONE CORPORATION (JP) | 2019-07-11 | — | — | US | disclosed |
| WO-2011028523-A2 | PROCESS AND CATALYST SYSTEM FOR POLYDIENE PRODUCTION | BRIDGESTONE CORPORATION (JP) | 2011-03-10 | — | — | WO | disclosed |
| EP-1620068-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL (FR) | 2006-02-01 | — | — | EP | disclosed |
| WO-2004087077-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL (FR) | 2004-10-14 | — | — | WO | disclosed |
| US-5736471-A | MONOFILAMENT WITH NAPHTHYL REPEAT UNIT ALONG THE POLYESTER BACKBONE PROVIDES A MATERIAL WITH DIMENSIONAL STABILITY, NONHYDROLYZING, ABRASION AND CHEMICAL RESISTANT; FILTERS | HOECHST TREVIRA GMBH & CO KG (DE) | 1998-04-07 | — | — | US | disclosed |
| US-5652057-A | POLYESTER | HOECHST TREVIRA GMBH & CO. KG (DE) | 1997-07-29 | — | — | US | disclosed |
| EP-0102596-B1 | PROCESS FOR PREPARING POLYURETHANE ELASTOMERS UTILISING DIOLS OF THE DIANHYDRO-HEXITOL-TYPE IN CONNECTION WITH POLYOXYALKYLENE-POLYDIALKYL SILOXANE COPOLYMERS | BAYER AG (DE) | 1988-05-11 | — | — | EP | disclosed |
| EP-0107838-A2 | Polyurethane \"high-solid\" reactive coating systems incorporating a levelling agent, and their use in reactive coating | BAYER AG (DE) | 1984-05-09 | — | — | EP | disclosed |
| EP-0102596-A2 | Process for preparing polyurethane elastomers utilising diols of the dianhydro-hexitol-type in connection with polyoxyalkylene-polydialkyl siloxane copolymers | BAYER AG (DE) | 1984-03-14 | — | — | EP | disclosed |
| US-4139479-A | Textile treating composition | THE PROCTER & GAMBLE COMPANY (US) | 1979-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10899718-B2 | Polymers functionalized with N-protected hydantoin compounds | HNMT, PARG, PAM | TSHR 4794/4885THRB 4878/4885LMNA 455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.